Christopher J. Gill, MD

Associate Professor, Global Health
Christopher Gill
(617) 638-6584cgill@bu.edu
Crosstown Center – 370
View full profile at BUMC

Biography

Christopher Gill has an MD from the University of Massachusetts Medical School and an MS from Tufts-Sackler School of Graduate Biomedical Studies.Dr. Gill is an infectious disease specialist by training. From 2002-2008 he was a faculty member of the Department of Global Health at Boston University School of Public Health, engaged in a wide variety of clinical trials and investigations. His research interests have focused on child survival, and include diarrheal diseases, tuberculosis, pneumococcal and meningococcal disease, adherence to HIV medications, and neonatal survival. He was the principal investigator of the Lufwanyama Neonatal Survival Project in Northern Zambia (LUNESP), a prospective, cluster randomized and controlled effectiveness study designed to determine whether training traditional birth attendants to manage several common perinatal conditions could reduce neonatal mortality in the setting of a resource poor country with limited access to healthcare. The results demonstrated that training traditional birth attendants in neonatal resuscitation skills significantly reduces neonatal mortality by approximately 50%. From 2008-end of 2010 he was the Director of the Meningitis ACWY conjugate vaccine clinical trials group at Novartis Vaccines. There he was responsible for the design, implementation and analysis of Phase IIb, III and IV clinical trials in support of the vaccine, and played a key role in licensing this new vaccine in over 60 countries around the world, including the US. In 2011, he rejoined the faculty at the BU Center for Global Health and Development and the BU School of Public Health, working as the Director of the BUSPH Pharmaceuticals Program from 2011-15, teaching, mentoring, and conducting research in the areas of HIV medication adherence in China, advocacy around child mortality due to diarrhea and pneumonia, pertussis and RSV disease surveillance in Zambia, and capacity building of Vietnamese community health workers using SMS text messaging. Dr. Gill is the 2015 recipient of the Norman Scotch Award for excellence in teaching at Boston University School of Public Health, and the 2016 recipient of Boston University's Metcalf Cup and Prize. The Metcalf Cup and Prize is BU's highest teaching honor, and is awarded to one of BU's >3500 faculty across its 17 colleges and schools each year.

Education

  • University of Massachusetts Medical School, MD
  • Tufts University, MS
  • Tufts University, BS

Classes Taught

  • SPHPH739

Publications

  • Published on 4/10/2018

    Larson Williams A, McCloskey L, Mwale M, Mwananyanda L, Murray K, Herman AR, Thea DM, MacLeod WB, Gill CJ. "When you are injected, the baby is protected:" Assessing the acceptability of a maternal Tdap vaccine based on mothers' knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia. Vaccine. 2018 05 17; 36(21):3048-3053. PMID: 29653846.

    Read at: PubMed
  • Published on 3/12/2018

    Sabin LL, Mansfield L, DeSilva MB, Vian T, Li Z, Wubin X, Gifford AL, Barnoon Y, Gill CJ. Why it Worked: Participants' Insights into an mHealth Antiretroviral Therapy Adherence Intervention in China. Open AIDS J. 2018; 12:20-37. PMID: 29576816.

    Read at: PubMed
  • Published on 2/26/2018

    Gill CJ, Le NB, Halim N, Chi CTH, Nguyen VH, Bonawitz R, Hoang PV, Nguyen HL, Huong PTT, Larson Williams A, Le NA, Sabin L. mCME project V.2.0: randomised controlled trial of a revised SMS-based continuing medical education intervention among HIV clinicians in Vietnam. BMJ Glob Health. 2018; 3(1):e000632. PMID: 29527350.

    Read at: PubMed
  • Published on 8/25/2017

    Gill C, Rohani P, Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res. 2017; 6:1568. PMID: 28928960.

    Read at: PubMed
  • Published on 6/27/2017

    Sabin LL, Larson Williams A, Le BN, Herman AR, Viet Nguyen H, Albanese RR, Xiong W, Shobiye HO, Halim N, Tran LTN, McNabb M, Hoang H, Falconer A, Nguyen TTT, Gill CJ. Benefits and Limitations of Text Messages to Stimulate Higher Learning Among Community Providers: Participants' Views of an mHealth Intervention to Support Continuing Medical Education in Vietnam. Glob Health Sci Pract. 2017 Jun 27; 5(2):261-273. PMID: 28655802.

    Read at: PubMed
  • Published on 6/19/2017

    Gill CJ, Hodsdon L, Santosham M, O'Brien KL. The unattainable criteria for new infant vaccines. Hum Vaccin Immunother. 2018 May 04; 14(5):1179-1187. PMID: 28509601.

    Read at: PubMed
  • Published on 6/1/2017

    Gill CJ, Thea DM, Hibberd P. Diarrhoeal disease trends in the GBD 2015 study: optimism tempered by scepticism. Lancet Infect Dis. 2017 Sep; 17(9):884-885. PMID: 28579425.

    Read at: PubMed
  • Published on 1/14/2017

    Brennan AT, Bonawitz R, Gill CJ, Thea DM, Long L, Fox MP. Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al. AIDS. 2017 Jan 14; 31(2):317. PMID: 28002088.

    Read at: PubMed
  • Published on 12/12/2016

    Lapidot R, Gill CJ. The Pertussis resurgence: putting together the pieces of the puzzle. Trop Dis Travel Med Vaccines. 2016; 2:26. PMID: 28883970.

    Read at: PubMed
  • Published on 12/12/2016

    Lapidot R, Gill CJ. The resurgence of pertussis: putting together the pieces of the puzzle. BMC Tropical Diseases, Travel Medicine and Vaccines. 2016; 26(2).

View 92 more publications:View full profile at BUMC

News & In the Media